Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ALRECO 40400

K-Number: K951926 · 1995-12-08

Decision Date1995-12-08
Product CodeBTI
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

ALRECO 40400 is the device name listed in this FDA 510(k) record. The listed applicant is Allan Rehnstrom AB. It received FDA 510(k) clearance on 1995-12-08 under 510(k) number K951926. The device is classified under product code BTI. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ALRECO 40400?

ALRECO 40400 is a medical device that received FDA 510(k) clearance on 1995-12-08. The listed applicant is Allan Rehnstrom AB. The 510(k) number is K951926.

When did ALRECO 40400 receive FDA 510(k) clearance?

ALRECO 40400 received FDA 510(k) clearance on 1995-12-08, under 510(k) number K951926.

Who is the listed applicant for ALRECO 40400?

The FDA 510(k) record lists Allan Rehnstrom AB as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ALRECO 40400?

The FDA product code for ALRECO 40400 is BTI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: BTI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑